Currency in USD
Earnings estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | -0.23 | -0.21 | -0.78 | -0.58 |
Low estimate | -0.23 | -0.21 | -0.78 | -0.58 |
High estimate | -0.23 | -0.21 | -0.78 | -0.58 |
Year ago EPS | -0.37 | -0.28 | -1.26 | -0.78 |
Revenue estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | 6.9M | 8.4M | 35.5M | 46.5M |
Low estimate | 6.9M | 8.4M | 35.5M | 46.5M |
High estimate | 6.9M | 8.4M | 35.5M | 46.5M |
Year ago sales | 6.32M | 8.6M | 27.51M | 35.5M |
Sales growth (year/est) | 9.20% | -2.30% | 29.00% | 31.00% |
Earnings history | 30/03/2023 | 29/06/2023 | 29/09/2023 | 30/12/2023 |
---|
Est. EPS | -0.37 | -0.32 | -0.3 | -0.22 |
Actual EPS | -0.37 | -0.28 | -0.37 | -0.23 |
Difference | 0 | 0.04 | -0.07 | -0.01 |
Surprise % | 0.00% | 12.50% | -23.30% | -4.50% |
EPS trend | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
Current estimate | -0.23 | -0.21 | -0.78 | -0.58 |
7 days ago | -0.23 | -0.21 | -0.78 | -0.58 |
30 days ago | -0.23 | -0.21 | -0.78 | -0.58 |
60 days ago | -0.23 | -0.21 | -0.77 | -0.61 |
90 days ago | -0.14 | -0.17 | -0.32 | 0 |
EPS revisions | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | TBIO | Industry | Sector(s) | S&P 500 |
---|
Current qtr. | 37.80% | N/A | N/A | N/A |
Next qtr. | 25.00% | N/A | N/A | N/A |
Current year | 38.10% | N/A | N/A | N/A |
Next year | 25.60% | N/A | N/A | N/A |
Next 5 years (per annum) | N/A | N/A | N/A | N/A |
Past 5 years (per annum) | N/A | N/A | N/A | N/A |